SCHEMBL95851

SCHEMBL95851

Cc1cccc(-c2noc(C(C)O)n2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.57
NPC1 O15118 9/20 0.56
CASP3 P42574 3/20 0.56
SENP7 Q9BQF6 3/20 0.56
POLB P06746 1/20 0.56
SMN1; SMN2 Q16637 6/20 0.54
TP53 P04637 4/20 0.54
MAPT P10636 1/20 0.52
L3MBTL1 Q9Y468 3/20 0.51
TSHR P16473 3/20 0.51
MAPK1 P28482 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KCNT1 Q5JUK3 4/20 0.51
HSD17B10 Q99714 3/20 0.50
SENP6 Q9GZR1 2/20 0.50
KDM4E B2RXH2 2/20 0.50
SENP8 Q96LD8 1/20 0.50
ALDH1A1 P00352 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12377805 0.88 RAB9A (0.60) RAB9ANPC1CASP3SENP7POLB
SCHEMBL95850 0.86 RAB9A (0.58) RAB9ANPC1CASP3SENP7POLB
SCHEMBL22637769 0.85 RAB9A (0.57) RAB9ANPC1CASP3SENP7POLB
SCHEMBL22637349 0.85 RAB9A (0.57) RAB9ANPC1CASP3SENP7POLB
SCHEMBL22637351 0.85 RAB9A (0.57) RAB9ANPC1CASP3SENP7POLB
Hydrochloric Acid SCHEMBL22637856 0.84 RAB9A (0.56) RAB9ANPC1CASP3SENP7POLB
SCHEMBL1544896 0.84 MAPT (0.53) RAB9ANPC1SMN1; SMN2TP53MAPT
SCHEMBL4657888 0.84 MAPT (0.53) RAB9ANPC1SMN1; SMN2TP53MAPT
SCHEMBL22637840 0.81 KCNT1 (0.64) RAB9ASMN1; SMN2TP53TSHRMAPK1
SCHEMBL22637723 0.81 KCNT1 (0.64) RAB9ASMN1; SMN2TP53TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB RAB9A 3886/4885NPC1 2361/4885CASP3 2486/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 RAB9A 2273/4885NPC1 2922/4885CASP3 2833/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 RAB9A 2273/4885NPC1 2922/4885CASP3 2833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.